20210804_erenumab_Headache_SB_01
收藏Zenodo2021-09-10 更新2026-05-25 收录
下载链接：
https://zenodo.org/record/5163219
下载链接
链接失效反馈官方服务：
资源简介：
Dataset refers to the evaluation of psychological predictors of the outcome of 12-month of treatment with Erenumab in Chronic Migraine patients: Responders (reduction ≥ 50% in migraine days) vs Non Responders (reduction < 50% in migraine days). To this end, patients at baseline received a full psychological evaluation using The Structured Clinical Interview for DSM-5 Clinician Version (SCID-5-CV) to assess mood, anxiety, and personality disorders as well specific questionnaires to evaluate alexithymia traits, childhood traumas, and current life-event stressors. Results highlighted that the presence of current stressors, anxiety and Cluster C personality disorders represent negative predictors of treatment outcome.
提供机构：
Zenodo
创建时间：
2021-09-10
